NVAX FY 2021 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$198M+782.5% YoY

Gross Profit

$198M100.0% margin

Operating Income

-$1.7B-853.6% margin

Net Income

-$1.7B-882.5% margin

EPS (Diluted)

$-23.44

Cash Flow

Operating Cash Flow

$323M

Free Cash Flow

$265M

Stock-Based Comp.

$184M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$2.9B

Stockholders' Equity

-$352M

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$198M	$22M	+782.5%
Gross Profit	$198M	$22M	+782.5%
Operating Income	-$1.7B	-$417M	-304.7%
Net Income	-$1.7B	-$418M	-316.9%